Neogenomics Inc
NASDAQ:NEO

Watchlist Manager
Neogenomics Inc Logo
Neogenomics Inc
NASDAQ:NEO
Watchlist
Price: 16.245 USD -0.64% Market Closed
Market Cap: 2.1B USD
Have any thoughts about
Neogenomics Inc?
Write Note

Neogenomics Inc
Cash Equivalents

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Neogenomics Inc
Cash Equivalents Peer Comparison

Comparables:
TMO
DHR
MTD
A
IQV

Competitive Cash Equivalents Analysis
Latest Figures & CAGR of Competitors

Company Cash Equivalents CAGR 3Y CAGR 5Y CAGR 10Y
Neogenomics Inc
NASDAQ:NEO
Cash Equivalents
$362m
CAGR 3-Years
2%
CAGR 5-Years
15%
CAGR 10-Years
27%
Thermo Fisher Scientific Inc
NYSE:TMO
Cash Equivalents
$4.6B
CAGR 3-Years
-27%
CAGR 5-Years
30%
CAGR 10-Years
24%
Danaher Corp
NYSE:DHR
Cash Equivalents
$2.6B
CAGR 3-Years
1%
CAGR 5-Years
-29%
CAGR 10-Years
-4%
Mettler-Toledo International Inc
NYSE:MTD
Cash Equivalents
$70.8m
CAGR 3-Years
-21%
CAGR 5-Years
-11%
CAGR 10-Years
-4%
Agilent Technologies Inc
NYSE:A
Cash Equivalents
$1.8B
CAGR 3-Years
8%
CAGR 5-Years
0%
CAGR 10-Years
-3%
IQVIA Holdings Inc
NYSE:IQV
Cash Equivalents
$1.6B
CAGR 3-Years
2%
CAGR 5-Years
13%
CAGR 10-Years
9%

See Also

What is Neogenomics Inc's Cash Equivalents?
Cash Equivalents
362m USD

Based on the financial report for Sep 30, 2024, Neogenomics Inc's Cash Equivalents amounts to 362m USD.

What is Neogenomics Inc's Cash Equivalents growth rate?
Cash Equivalents CAGR 10Y
27%

Over the last year, the Cash Equivalents growth was 18%. The average annual Cash Equivalents growth rates for Neogenomics Inc have been 2% over the past three years , 15% over the past five years , and 27% over the past ten years .

Back to Top